SkinnyRx review

What you get here is a real microdose product rather than a smaller amount of somebody else's plan: there are distinct microdose SKUs for both injectable semaglutide and injectable tirzepatide, a microdosing page, a funnel that branches on it, and its own consent step. It also does something worth crediting, because almost nobody here does it — its microdosing consent says outright that the term is descriptive only, is not a recognized dosing category, and carries no assumption of reduced risk, which is closer to what the evidence supports than most of the marketing here. What it does not do is charge you less for taking less. Line its two ladders up and the microdose products cost exactly what the full-dose products cost at every term the two have in common, and because the microdose line stops at an eight-month commitment while the full-dose line runs to twelve, the cheapest rate a microdoser can reach is higher than the cheapest rate a full-dose buyer can reach. Read the price field before comparing it with anything else here, too: every figure the storefront displays is that product's longest-commitment rung, printed under the words as low as, and the month-to-month rate is rendered on no page of the site.

Vs median

$180/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

SkinnyRx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

SkinnyRx (skinnyrx.com) is a compounded-GLP-1 telehealth storefront with an unusually wide catalog: semaglutide and tirzepatide as once-weekly injections, a compounded tirzepatide tablet, an oral semaglutide, and — the reason it is here — dedicated microdose versions of both injectables, sold as distinct products rather than as a smaller vial of the standard plan. An online intake is reviewed by a licensed provider after checkout, and microdosing is routed as its own funnel with its own consent step. What a low-dose reader most needs to know is the price structure. Every figure the storefront shows is that product's longest-commitment rung, printed under the words "As low as", and the month-to-month rate appears on no page: semaglutide advertised at $199/mo is $349 by the month, tirzepatide advertised at $299/mo is $399. The microdose products are priced identically to the full-dose ones at every rung they share, and because the microdose line stops at an eight-month commitment while the full-dose line runs to twelve, its cheapest possible rate is higher than the full-dose product's. No dispensing pharmacy, corporate entity or LegitScript ID is published anywhere on the site.

Microdosing here is not a cheaper way in: the microdose SKUs are priced identically to the full-dose products at every rung they share, and because the microdose line has no twelve-month tier its best possible rate is HIGHER than the full-dose product's — $229 against $199 for semaglutide, $319 against $299 for tirzepatide. You pay the same or more for less medication

• Every price the site displays is its longest-commitment rung, labeled "As low as" — the month-to-month rate ($349 semaglutide, $399 tirzepatide, microdose or not) is rendered on no page of the site
• The struck-through $329 shown beside injectable semaglutide matches no plan on its own ladder ($199/$249/$299/$349)
• The FDA issued this company a warning letter in February 2026; the letter is public in the FDA's warning-letter database
• Not available in Alabama, Mississippi or Louisiana, and no served-states list is published anywhere on the site
• The Wegovy® and Foundayo™ pills the storefront advertises both show "Unavailable", and no brand tirzepatide is sold at all — the $49 attached to those pills is a membership fee, not a medication price
• No dispensing pharmacy, corporate entity or LegitScript ID is named anywhere on the site; 503A is referenced only generically in the FAQ
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

SkinnyRx is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• Microdose & reconstitution calculator
• Titration planner